PLEASANTON, Calif., Sept. 01, 2016 -- The Cooper Companies, Inc. (NYSE:COO) today announced that Gregory W. Matz, senior vice president, chief financial officer and chief risk officer, plans to retire from the company in early 2017 after more than six years of service to the company. As part of his planned transition, Mr. Matz intends to remain in his current role through fiscal year end October 31, 2016, and then act in an advisory capacity until March 2017 to ensure a smooth transition. Albert G. White, III will succeed Mr. Matz as chief financial officer, effective November 1, 2016. Mr. White will assume this role in addition to his current responsibilities as executive vice president and chief strategy officer of Cooper Companies, which includes responsibility for leading CooperSurgical.
“Greg has played a key role in helping Cooper deliver meaningful returns to our shareholders. On behalf of our Company, I want to thank him for his service and wish him the best in his retirement and future endeavors,” said Robert S. Weiss, Cooper’s president and chief executive officer.
Weiss added, “Al is a true professional with deep knowledge of the Cooper business built since joining the Company in 2006. He has excelled in key leadership positions at Cooper including leading CooperSurgical, strategy, treasury, IR, and communications. He also worked closely with Cooper in a banking capacity for many years prior to joining the company. I am highly confident in Al’s leadership and capabilities required for this expanded role.”
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
CONTACT: Kim Duncan Vice President, Investor Relations The Cooper Companies, Inc. [email protected]


MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 



